According to the current revised laboratory criteria for APS[41], both lupus anticoagulant and aCL IgG and IgM are maintained as laboratory APS criteria, and IgM and IgG anti-ß2 glycoprotein-I assays are added in the revised criteria. The gene discussed is ACLY; the disease is autoimmune polyendocrinopathy.